Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

lonidamine-encapsulating PEGylated peptide nanoparticles

Based on

1 Articles
2017 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

peptide/protein

Type Biomolecule
Formula
Role carriers
2

lonidamine

LND
Type Single Compound
Formula C15H10Cl2N2O2
Role loaded material

Properties

General physical and chemical properties

Property Value Source
colloidal stability

More information available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Source
HCC1806 human breast cancer tumor-bearing female NCR-athymic nu/nu mouse

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Product

lonidamine-encapsulating PEGylated peptide nanoparticles

Method 2

Type: Physical formation
Source:
Product

lonidamine-encapsulating PEGylated peptide nanoparticles

Method 3

Type: Physical formation
Source:
Starting materials
  • lonidamine
  • peptide/protein
  1. c63ovRPkWk839fcwB2CKzehFA
Product

lonidamine-encapsulating PEGylated peptide nanoparticles

Method 4

Type: Physical formation
Source:
Product

lonidamine-encapsulating PEGylated peptide nanoparticles

Method 5

Type: Physical formation
Source:
Starting materials
  • lonidamine
  • peptide/protein
  1. gS37AecH3jhy0y0vqUhnZ8Vzh
Product

lonidamine-encapsulating PEGylated peptide nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial